The QualityStocks Daily Friday, June 21st, 2019

Today's Top 3 Investment Newsletters

QualityStocks (TAKD) +317.39%

Damn Good Penny Picks (CMPY) +37.39%

MarketBeat (AXGT) +18.48%

The QualityStocks Daily Stock List

Patriot One Technologies, Inc. (PTOTF)

NetworkNewsWire, Profit Confidential, Midas Letter, Streetwise Reports, Micro Small Cap, Playstocks, Stockhouse, and Insider Financial reported previously on Patriot One Technologies, Inc. (PTOTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Patriot One Technologies, Inc. engages in the research, development, and commercialization of a system to detect concealed weapons using radar technologies. A technology enterprise, the Company’s mission is to be the foremost global solutions provider for public safety. It works to deliver unique threat detection and counter-terrorism solutions for safer communities. OTCQX-listed, Patriot One Technologies is headquartered in Vancouver, British Columbia.

The Company aims to address the spread of active violence through superior detection technology that immediately identifies concealed weapons. Its PATSCAN™ Multi-Sensor Covert Threat Detection Platform provides a network of advanced sensor technologies with powerful next generation AI/machine learning software. This network can be covertly deployed from far perimeter to interiors across manifold weapons-restricted facilities.

The PATSCAN™ platform identifies and reports threats wherever required; car park, building approach, employee & public entryways, and also inside the facilities. Each solution in the platform identifies weapons, related threats or disturbances for instant security response. Patriot One is commercializing its PATSCAN™ CMR technology as an automated alert system capable of covertly screening moving individuals for on-body concealed weapons. This includes handguns, knives, grenades, explosive vests, and more.

Patriot One Technologies and a respected university led research team have developed the foundation for portable devices and software solutions to assist military and civilian security personnel in the detection of concealed weapons. The technology is intended to be placed in key access points. It utilizes radio wave emissions to safely target, identify and notify of concealed threat potential through software recognition of specific wavelength patterns.

Recently, Patriot One Technologies announced that it entered into a binding reseller agreement with West Virginia-based Cramer Security & Investigations, Inc. to distribute Patriot One’s PATSCAN VRS commercial units. This Agreement is for an initial term of five years, and with the Agreement Cramer Security has acquired an initial 3-year lease of the solution as a first phase approach to deploying the PATSCAN multi-sensor covert threat detection platform across a wide spectrum of its end customers.

This Agreement requires Cramer Security to use its commercially best efforts to deploy at least 150 PATSCAN VRS systems, including associated software license, maintenance and support, that, provided the minimum yearly commitment is met, represents a value of $6,285,166 CAD ($4,672,800 USD) over this 3-year lease period. This Agreement includes minimum yearly sales requirements in order for Cramer Security to maintain its System pricing equal to 50 Systems in the first year, no less than 100 Systems by the end of the second year, and no less than 150 Systems by the end of the third year.

Patriot One Technologies, Inc. (PTOTF), closed Friday's trading session at $1.4195, up 3.61%, on 41,630 volume with 58 trades. The average volume for the last 3 months is 155,339 and the stock's 52-week low/high is $0.9259/$2.289.

chart

Oramed Pharmaceuticals, Inc. (ORMP)

Awesome Penny Stocks, Infront Analytics, Zacks, PR Newswire, StreetWise Reports, Macro Trends, StockNews, and OTC Markets reported earlier on Oramed Pharmaceuticals, Inc. (ORMP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A clinical-stage pharmaceutical company, Oramed Pharmaceuticals, Inc. focuses on the development of oral drug delivery systems. The Company is a platform technology pioneer in the field of oral delivery solutions for drugs presently delivered through injection. It has developed a novel Protein Oral Delivery (POD™) technology. This technology is based on greater than three decades of research by scientists at Jerusalem's Hadassah Medical Center. Oramed Pharmaceuticals has offices in New York and Israel.

The Company is working to revolutionize the treatment of diabetes via its proprietary lead candidate, ORMD-0801, which has the potential to be the first commercial oral insulin capsule for the treatment of Type 2 and Type 1 diabetes. Oramed has completed numerous Phase II clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration (FDA). The Company is also developing an oral GLP-1 (Glucagon-like peptide-1) analog capsule, ORMD-0901, that has potential to be the first orally-ingestible GLP-1 analog.

The design of Oramed’s POD™ (Protein Oral Delivery) technology has been to protect orally delivered proteins from detrimental enzymatic activity within the gastrointestinal tract and to enhance their absorption across the intestinal wall. The active protein is encapsulated in a capsule that features a highly protective coating that remains intact in the most acidic segments of the gut, and enzymatic support provided by specialized protease inhibitors. Drug availability is further secured by an absorption enhancer supplement, which facilitates protein passing across the intestinal barrier.

In May, Oramed Pharmaceuticals announced that it completed enrollment for its 90-day dose-ranging Phase IIb clinical study of its oral insulin capsule main cohort. Almost 300 patients have now been enrolled. Furthermore, 70 percent (more than 200) of these patients have completed treatment in the study.

This week, Oramed Pharmaceuticals provided a clinical update regarding four ongoing clinical programs. Oramed Chief Executive Officer, Nadav Kidron, said, "All of our clinical programs continue to advance on-track as planned with no related serious adverse safety issues. We expect to provide meaningful clinical results from these ongoing trials in the coming months. We believe we have a unique oral technology platform that has the potential to revolutionize the effective delivery of important medication to improve treatment of diabetes and related conditions."

Oramed Pharmaceuticals, Inc. (ORMP), closed Friday's trading session at $3.5508, up 1.45%, on 22,718 volume with 127 trades. The average volume for the last 3 months is 76,071 and the stock's 52-week low/high is $2.779/$7.679.

chart

Troubadour Resources, Inc. (TROUF)

Investor Ideas, Resource Maven, MineStat, Investorx, Stockwatch, Stockhouse, Northern Miner, Insider Tracking, and Junior Mining Network reported previously on Troubadour Resources, Inc. (TROUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Troubadour Resources, Inc. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It explores for copper and gold deposits. The Company was previously known as Grandore Resources, Inc. It changed its name to Troubadour Resources, Inc. in February of 2017. The Company is based in Vancouver, British Columbia.

Troubadour Resources has its Amarillo Copper Project. The Amarillo Property comprises 7 mineral claims encompassing 4,178 hectares. It is positioned in the heart of a major mining district. The project is 30km West of Peachland, with access along the Peachland FSR logging road from Highway 97. The multi-element signature of the Amarillo Copper Project area is consistent with a large multi-phase mineralizing system. It is very similar to some of the neighbouring world-class mining operations.

Earlier this month, Troubadour Resources provided notice that it will no longer be proceeding with the acquisition of Privateer Gold Mines as announced on March 5, 2019. The letter of intent (LOI) was entered into on February 28, 2019 with Surespan Ltd. and its wholly-owned subsidiary, Privateer Gold Ltd., granting an option to Troubadour to acquire all of the issued and outstanding shares of Privateer.

Privateer is the owner of the Surespan gold property (Privateer Gold Mines) that encompasses the historic Zeballos high-grade gold mining camp on the northwest coast of Vancouver Island, British Columbia (B.C.), near the town of Zeballos. On May 28, 2019, the LOI was terminated without a definitive agreement being entered into between the parties.

Last week, Troubadour Resources announced it mobilized field crews to its 100 percent owned Amarillo Cu-Au Porphyry project in southwestern B.C. The planned field work will comprise prospecting, geochemical sampling, geological mapping and a drone survey over high priority areas to further define drill targets for a follow-up exploration drill program starting in the coming weeks. The Amarillo remains Troubadour Resources’ flagship project and will be the focus of its exploration efforts for the foreseeable future.

Troubadour Resources, Inc. (TROUF), closed Friday's trading session at $0.06719, even for the day, on 12,000 volume. The average volume for the last 3 months is 6,448 and the stock's 52-week low/high is $0.0566/$0.109.

chart

Benchmark Metals, Inc. (CYRTF)

High Rising Stocks, Investor Ideas, Geology for Investors, The Prospector News, Trading View, Stockwatch, Resource World, Mining Stock Education, Investcom, GlobeNewswire, OTC Markets, Investors Hangout, Dividend Investor, Northern BC Mining, Wallet Investor, Barchart, Market Screener, Junior Mining Network, and Stockhouse reported earlier on Benchmark Metals, Inc. (CYRTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Benchmark Metals, Inc. is a mineral exploration company headquartered in Edmonton, Alberta. A junior resource company, it engages in the identification, evaluation, acquisition, and exploration of mineral properties. The Company previously went by the name Crystal Exploration, Inc. It changed its corporate name to Benchmark Metals, Inc. in May of last year. Incorporated in 2010, Benchmark Metals lists on the OTC Markets Group’s OTCQB.

The Company concentrates on proving and developing the considerable resource potential of the Lawyer’s Gold and Silver project, situated in the prolific Golden Triangle of northern British Columbia. The Lawyers Property is positioned 45 km northwest of the Kemess Copper-Gold Mine, which has started underground development and construction.

Lawyers is situated in the Toodoggone region of the Omineca Mining Division of British Columbia. It comprises 37 contiguous mineral claims. The claims encompass 9,860 hectares (99km2) of land that cover the Lawyers group of prospects, including the former Lawyers underground gold-silver mine and the Silver Pond group of prospects, and includes more than 16 gold-silver mineral occurrences.

In Nunavut Territory, Benchmark Metals owns 100 percent of the Muskox Project that totals near 600km2.The Muskox Project has been previously explored by several private and public companies over the years. Benchmark Metals has identified a minimum of 6 new geophysical targets for new discovery drilling. Some of the new targets are supported by historical and new work, which includes kimberlite and mantle indicator minerals (KIMs). This includes G9 and G10 garnets in kimberlite mineral dispersal trains.

Last week, Benchmark Metals provided drilling plans and historical results at the Amethyst Gold Breccia Zone (AGB), located within the regional Lawyers Trend. Selected historical high-grade drilling intersected 108.36 g/t gold and 911.2 g/t silver over 7 meters (DDH81AS43) core length and 6.96 g/t gold and 254.70 g/t silver over 57.9 meters (DDH82AS16) core length. The Lawyers Project is in the Stikine Terrane of northern British Columbia. It falls within the prolific, mineral endowed 'Golden Horseshoe’.

The 2019 drilling program for the AGB Zone will commence by concentrating on step-out and deeper drilling targeting mineralization where the geochemistry, potassic alteration, and geophysical anomalies indicate a total signature length of 500-plus meters. Furthermore, the limited historical drilling to the east of the main zone, and also a large historic soil anomaly to the east, suggest there is potential for a substantial parallel lode.

Benchmark Metals, Inc. (CYRTF), closed Friday's trading session at $0.217, off by 5.65%, on 10,500 volume with 2 trades. The average volume for the last 3 months is 30,784 and the stock's 52-week low/high is $0.1126/$0.3033.

chart

Blue Sky Uranium Corp. (BKUCF)

StockPulse, Wealth Daily, Investor Intel, Streetwise Reports, Market Trend News, Mining Feeds, Micro Small Cap, Stockhouse, OTC Markets, PR Newswire, and Junior Mining Network reported earlier on Blue Sky Uranium Corp. (BKUCF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Blue Sky Uranium Corp. is a leader in uranium discovery in Argentina. Its goal is to deliver exceptional returns to shareholders through rapidly advancing a portfolio of surficial uranium deposits into low-cost producers. The Company is a member of the Grosso Group, a resource management group that has pioneered exploration in Argentina since 1993. Blue Sky Uranium has its corporate office in Vancouver, British Columbia. It also has its Argentina Exploration Office in Mendoza.

The Company has the exclusive right to properties in two provinces in Argentina. Blue Sky’s flagship Amarillo Grande Project was an in-house discovery of a new district, which has the potential to be a top domestic supplier of uranium to the growing Argentine market and a new worldwide market supplier. Blue Sky Uranium has greater than 4,000 km2 (400,000 ha) of prospective tenements.

The Company’s exploration work between 2007 and 2012 led to the discovery of a new uranium district in Rio Negro Province. Blue Sky’s Amarillo Grande Project encompasses the district with three major properties. This includes the Ivana near-surface uranium deposit that hosts the largest NI 43-101 uranium resource in the nation. In addition, Ivana has potentially significant vanadium credits. Other exploration targets for blind uranium and vanadium mineralization are also present within the project area.

Last month, Blue Sky Uranium provided an update on present exploration and planned follow-up programs for its wholly-owned Amarillo Grande Uranium-Vanadium Project in Rio Negro, Argentina (AGP). The AGP encompasses a 145 km prospective trend, including the Ivana deposit that demonstrated strong economic potential in a recent NI 43‑101 Preliminary Economic Assessment (PEA).

Work so far has identified three high-priority target areas with significant anomalies of uranium and vanadium. The design of the exploration program for the next six months, including RC drilling, is to systematically identify and delineate mineralization potentially extending the Ivana deposit to the west (Ivana West target). Moreover, the program will test targets in two other key areas, Ivana Central and Ivana North, within 25 kilometers of the deposit.

Blue Sky Uranium Corp. (BKUCF), closed Friday's trading session at $0.117, up 0.86%, on 39,700 volume with 9 trades. The average volume for the last 3 months is 72,000 and the stock's 52-week low/high is $0.0933/$0.18.

chart

Corvus Gold, Inc. (CORVF)

NetworkNewsWire, The Daily Gold, MineStat, Street Insider, Research Pool, Trading View, Investing News, Stockhouse, Marketbeat, GuruFocus, Real Investment Advice, Zacks, Stock News Now, Stock Digest, The Street, Wallet Investor, Junior Mining Network, InvestorsHub, Investors Hangout, Morningstar, The Prospector News, and Equity Clock reported beforehand on Corvus Gold, Inc. (CORVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Corvus Gold, Inc. acquires, explores, and develops mineral properties primarily in the USA. The Company’s mandate is to become a leading exploration and development company with the ultimate goal of becoming a non-operating gold producer with significant carried interest and royalty exposure. Corvus Gold’s chief mineral property is the North Bullfrog Project. This is a gold-silver mining project in northwestern Nye County, Nevada. OTCQX-listed, Corvus Gold is based in Vancouver, British Columbia.

The North Bullfrog Project consists of leased, patented, and unpatented mining claims covering an area of around 86.6 km2 comprising a mix of private mineral leases of patented federal mining claims and 1,057 federal unpatented mining claims. The Project is 10 km north of Beatty, Nevada, and 8 km north of the Bullfrog Mine previously operated by Barrick Gold Corporation. The North Bullfrog Project represents a large, low-sulphidation, epithermal bulk-tonnage gold system hosted in volcanic and sedimentary rocks. The project is 100 percent controlled by Corvus Gold.

In addition, Corvus Gold has its Mother Lode Project. This Project is 165 km northwest of Las Vegas, Nevada, 10 km east of Beatty, Nevada, and approximately 20 road km’s from Corvus’ North Bullfrog project in the Walker Land gold belt. The Mother Lode Project comprises 445 federal unpatented mining claims covering an area of about 36.5 km².

Last week, Corvus Gold announced it received assay results from the final five holes of the Mother Lode, Phase-III resource expansion program, targeting the northern and eastern extension of the deposit. The Company believes that the results continue to demonstrate the expansion potential of the deposit to the north and at depth where mineralization remains open. Of note, the most recent assay results also suggest that mineralization extends the full length of the property package, from the southern end of the historic pit along the Fluorspar Canyon Fault (FCF) north towards AngloGold’s Silicon property.

Mr. Jeff Pontius, President and Chief Executive Officer of Corvus Gold, said, “The results from the northern extension of the Mother Lode system are encouraging. In addition, we believe that our increased understanding of the new deep mineralization at the Mother Lode deposit could represent the potential for expansion of the system at depth. This new style of gold mineralization along with AngloGold’s recent Silicon discovery a few kilometers to the north, could have the potential to rewrite the exploration models for the greater Bullfrog District and increase the potential for large, high-grade, "Carlin style" gold systems in the area…”

                   

Corvus Gold, Inc. (CORVF), closed Friday's trading session at $1.60, off by 2.40%, on 26,059 volume with 37 trades. The average volume for the last 3 months is 14,003 and the stock's 52-week low/high is $1.129/$2.72.

chart

HempAmericana, Inc. (HMPQ)

MicroSmallCap, Penny Stock Tweets, Daily Marijuana Observer, Zacks, CannabisMarketCap, Pot Stock News, OTC Markets, Green Leaf Pot Stocks, Green Market Report, Real Investment Advice, Stock of the Week, and Make Penny Stocks Great Again reported earlier on HempAmericana, Inc. (HMPQ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

HempAmericana, Inc. is an emerging leader in the CBD (cannabidiol) products market. It owns and operates a high-capacity, state-of-the-art CBD extraction and processing facility in Augusta, Maine. The Company also owns and operates Union Farm, a high-potency CBD strain development facility located in Union, Maine. In addition, HempAmericana researches, develops, and sells products made of industrial hemp. This includes a popular brand of hemp rolling papers marketed under the brand name, “Rolling Thunders”. HempAmericana is headquartered in New York, New York.

HempAmericana’s CBD oil business uses the brand designation, “Weed Got Oil”. The Company’s CBD extraction and processing facility has a supersized, supercritical CO2 extraction system, centrifugal partition chromatography refinement technology, and a mechanized fully-automated CBD bottling system.

HempAmericana is positioning itself as a leader in the multi-billion dollar CBD market. It is focusing on high-capacity extraction, processing, and purification of related oils utilizing market-leading technology. HempAmericana will be using one of the largest and most efficient full-spectrum CBD extraction machines on the market.

The Company completed the new greenhouse installation at its genetic seedstock augmentation facility in Maine. HempAmericana purchased a seven-acre farm to serve as a base of engineering operations for the cultivation of a super-high-potency seedstock to fuel future CBD production. The greenhouse installation is the centerpiece of the facility. HempAmericana will add an additional structure for cross-pollination activities.

Last week, HempAmericana announced a new Purchase Order (PO) with Eagle Hemp of Florida for more than $175,500 for delivery of bottled CBD Oil, with additional orders to come as part of an unbounded long-term supply relationship. Eagle Hemp will finance all shipping, labeling, as well as bottling costs in addition to purchasing the final product at competitive pricing. HempAmericana will receive a three-dollar fee for bottling the finished product using its state-of-the-art technology. The 30 ml bottles will contain three different potencies of CBD suspended in an MCT-based oil.

This week, HempAmericana announced the purchase and imminent delivery of a Tamper Evident Neck Band Applicator for the application of plastic shrink bands and sleeve labels on its CBD Oil bottles. The design of the new machine is to place a tamper-evident band around the neck of bottled products, which is a mandatory feature for selling bottled tinctures commercially. With the machine, HempAmericana will be able to finalize already produced bottles of CBD Oil to make them commercially ready for shipment.

HempAmericana, Inc. (HMPQ), closed Friday's trading session at $0.0092, off by 1.08%, on 2,964,680 volume with 115 trades. The average volume for the last 3 months is 10,784,612 and the stock's 52-week low/high is $0.00529/$0.02769.

chart

Zinc One Resources, Inc. (ZZZOF)

NetworkNewsWire, 4-Traders, MarketWatch, YCharts, InvestorX, InvestorsHub, Market Screener, Wall Street Profiler, Streetwise Reports, InvestorIntel, Stock of the Week, Epic Stock Picks, All Penny Stocks, Stockhouse, Dividend Investor, Insider Financial, Marketwired, Investing News, Barchart, StockInvest, Wallet Investor, Investor Ideas, and Investors Hangout reported previously on Zinc One Resources, Inc. (ZZZOF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Zinc One Resources, Inc. concentrates on the acquisition, exploration and development of prospective and advanced zinc projects in mining-friendly jurisdictions. Its key assets are the past producing Bongará Zinc Mine Project and the Charlotte-Bongará Zinc Project in Peru. The Company formerly went by the name Rockridge Capital Corp. It changed its corporate name to Zinc One Resources, Inc. in January 2017. Zinc One Resources is based in Vancouver, British Columbia.

The Company acquired Forrester Metals, Inc. in June of 2017.  As a result, it acquired the Bongará Mine and Charlotte-Bongará Projects. Both host high-grade, nonsulphide zinc mineralization at or near the surface. At the Bongará Zinc Mine the mineralization is concentrated along and proximal to a NW – trending anticlinal axis over approximately 2.5 kilometers.

The Bongará Zinc Mine was mined in 2007 and 2008 by a previous owner by open-pit methods, dried at the site, and then shipped 540 kilometers westward to the coast where it was processed via a Waelz kiln. This is a processing technology usually applied to flue dust from steel mills to recover zinc. In August 2008, the mine was closed down mainly due to a drop in the price of zinc at that time.

The exploration upside at Charlotte-Bongará includes greater than 8,000 meters of drilling. This includes results of 29.5% Zn across 15.5 meters, 26.1% Zn across 12.5 meters, and 29.7% Zn across 11.5 meters.

Recently, Zinc One Resources announced the first National Instrument 43-101 (NI 43-101) Mineral Resource estimate for its Bongará Zinc Mine project in north-central Peru. Watts Griffis and McOuat Limited (WGM) prepared the estimate for the Company. A supporting NI 43-101 technical report will be available under Zinc One Resources’ profile on SEDAR at www.sedar.com and on the Company's website at www.zincone.com within 45 days of this release (dated February 5, 2019).

Zinc One Resources also recently announced the results of voting at the Company’s Annual General Meeting (AGM) of shareholders that took place on March 13, 2019, in Vancouver, British Columbia. Shareholders at the AGM approved all matters. This included the appointment of the four incumbent directors -  Dr. William C. Williams, Mr. Barry Girling, Mr. Greg Crowe, and Mr. Gunther Roehlig, for the following year, the re-appointment of Charlton & Co. LLP as auditors of Zinc One Resources, and the renewal of the Company's 10 percent rolling stock option plan.

Zinc One Resources, Inc. (ZZZOF), closed Friday's trading session at $0.0229, up 90.83%, on 2,000 volume with 1 trade. The average volume for the last 3 months is 15,587 and the stock's 52-week low/high is $0.01118/$0.1779.

chart

MMEX Resources Corp. (MMEX)

Discovery Stocks, HydroCarbonProcessing, Investors Hangout, MarketWatch, MicroCapDaily, Stockhouse, Business Wire, 4-Traders, InvestorsHub, Morningstar, OTC Markets, and Wallet Investor reported earlier on MMEX Resources Corp. (MMEX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MMEX Resources Corp. focuses on the acquisition, development and financing of oil, gas, refining and infrastructure projects in Texas and South America. The Company established to engage in the exploration, extraction, refining and distribution of oil, gas, petroleum products and electric power. A development-stage company, MMEX Resources is headquartered in Fort Stockton, Texas.

MMEX’s main areas of interest include the acquisition and potential development of refining, oil & gas assets in Texas, and the acquisition of oil and gas properties in Peru. In addition, main areas of interest include crude, oil and product export opportunities in Latin America, and the development of terminals, storage, refining, oil & gas in Brazil.

The Company’s projects include the Pecos County Refinery Project, Fort Stockton, Texas. Phase 1 of this project is a 10,000 BPD Crude Distillation Unit. Phase 2 is a 100,000 BPD Large-Scale Refinery. The project is in Sulfur Junction, about 20 miles northeast of Fort Stockton. The project is strategically positioned close to oil production in West Texas, with storage capability.

MMEX Resources signed an off-take agreement with Pilot Thomas Logistics. The off-take agreement is for the sale of its diesel fuel production from Phase 1 of the MMEX refinery project in Pecos County. In November 2017, MMEX Resources broke ground on Phase 1 of the MMEX Refinery Project in Pecos County. The agreement provides for Pilot Thomas Logistics to obtain 100 percent of the diesel production from Phase 1, roughly 4,200 barrels per day, for markets in the Permian Basin area principally for use in drilling operations.

MMEX Resources intends to develop a solar power project to provide electric power to its planned 10,000 barrel-per-day (BPD) crude distillation unit and its full-scale crude oil refinery in Pecos County near Fort Stockton, Texas.

In October 2018, MMEX Resources and Blanchard Industrial, LLC (BIL) announced that BIL will be the overall EPC contractor to complete the detailed engineering and to construct the planned Pecos County Crude Distillation Unit refinery earlier announced by MMEX. BIL is an industry leader in design, engineering, procurement and construction (EPC) solutions.

MMEX Resources Corp. (MMEX), closed Friday's trading session at $0.0062, up 37.78%, on 2,118,386 volume with 33 trades. The average volume for the last 3 months is 982,205 and the stock's 52-week low/high is $0.00449/$0.479.

chart

Inception Mining, Inc. (IMII)

Stock Commander, Dividend Investor, Investors Hangout, Marketwired, Simply Wall St, Barchart, Streetwise Reports, PennyStocks24, Information Solutions Group, Charms Investments, YCharts, Street Insider, and 4-Traders reported earlier on Inception Mining, Inc. (IMII),  and we report on the Company as well, here at the QualityStocks Daily Newsletter.  

Inception Mining, Inc. engages in the acquisition, exploration, and development of precious metal properties -  chiefly gold-related. Its primary target properties are those that have been the subject of historical exploration having considerable supporting data. OTCQB-listed, Inception Mining is headquartered in Murray, Utah.

The Company holds interest in the U.P. and Burlington Gold Mine. This includes two Federal patented mining claims in the County of Lemhi, Northwest of Salmon, Idaho. The U.P. and Burlington Mine is within the Salmon National Forest. The mine is considered to be within the Eureka Mining District. 

Clavo Rico Ltd. is Inception Mining’s wholly-owned subsidiary. It assumed management control of Clavo Rico’s operation, the Cerros Del Sur operation in Honduras, Central America. Clavo Rico has principal operations in Honduras. Clavo Rico operates two subsidiaries and holds other mining concessions. Inception Mining’s main mine is situated on the 200 hectare Clavo Rico Concession, in southern Honduras.

Inception Mining continues to make improvements in operations and recovery, along with increasing its ore resources at the Cerros del Sur operation. Mine management has secured more mineable properties on its concession. Several adjacent landowners have placed the surface rights of their lands under contract with the mine.

Inception Mining announced in August of 2014 that it entered into an Ore Processing Agreement with New Jersey Mill Joint Venture (NJ Mill), a floatation mill that can process 360 metric tonnes per day. The mill is in Kellogg, Idaho. NJ Mill will process Inception Mining's bulk samples.     

In October 2017, Inception Mining announced that it entered into a Joint Venture (JV) Agreement with Corpus Mining and Exploration Ltd., a company domiciled in the Turks and Caicos. The JV creates a new company, Corpus Gold LLC.

In September 2018, Inception Mining announced that it entered into a verbal cooperation agreement with Glen Eagle Resources, Inc. Under the terms of the cooperation agreement, Glen Eagle will process certain high-grade material contained in sulfides produced at the Clavo Rico Mine that cannot be heap leached at the Clavo Rico Mine site but can undergo processing at Glen Eagle’s Cobro Oro de Honduras processing facility. This cooperation agreement is beneficial for both companies because it enables the processing of certain high-grade material for processing that may not otherwise be processed.

Inception Mining, Inc. (IMII), closed Friday's trading session at $0.165, up 37.50%, on 1,001 volume with 2 trades. The average volume for the last 3 months is 21,943 and the stock's 52-week low/high is $0.00019/$0.55.

chart

Lexington Biosciences, Inc. (LXGTF)

Awesome Penny Stocks, Penny Stock Hub, MarketWatch, Morningstar, Interactive Brokers, TradingView, Dividend Investor, Tech Stock Insider, InvestorsHub, Wallet Investor, 4-Traders, and Market News Updates reported earlier on Lexington Biosciences, Inc. (LXGTF),  and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

A medical device company, Lexington Biosciences, Inc. is developing the HeartSentry. This is a new non-invasive diagnostic device to measure and monitor cardiovascular health through assessing the function of a person's vascular endothelium. This is the vital innermost lining of a person's cardiovascular system. The Company’s aim is to become a leader in the development of clinical grade cardiovascular self-measurement solutions for home and clinical use. Lexington Biosciences has offices in Vancouver, British Columbia; and Reno, Nevada. 

Lexington is engaged with the US FDA (Food and Drug Administration) and other regulatory agencies on the required product approvals for the HeartSentry.  HeartSentry targets the fast-growing self-measurement medical device sector. The design of the HeartSentry unit is to use Bluetooth and Cloud technology to provide up-to-date and accurate readings of an individual’s total cardiovascular health via electronic monitoring for risk-assessment and treatment effectiveness targeting the prevention of heart attack and stroke. 

HeartSentry is its flagship, and first device currently advancing to commercial deployment. The HeartSentry core technology underwent development at the University of California Berkeley over a fifteen-year research and development (R&D) period involving many research studies and product iterations resulting in a portfolio of numerous pending and issued patents licensed to Lexington Biosciences. 

Lexington Biosciences announced earlier this year the completion of the initial HeartSentry study conducted at San Francisco Bay-area Diablo Clinical Research. Lexington Biosciences’ goal is to make HeartSentry accurate, fast, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person's cardiovascular health.

Over this past summer, Lexington Biosciences completed its first phase of clinical testing at Diablo Clinical Research. The results of the study validated safety protocols, provided Lexington with critical information for product iteration, algorithm development, and clinical testing protocol refinement in preparation for the forthcoming multi-center clinical study series.

Lexington Biosciences, Inc. (LXGTF), closed Friday's trading session at $0.189985, up 50.83%, on 34,820 volume with 24 trades. The average volume for the last 3 months is 54,485 and the stock's 52-week low/high is $0.0546/$2.349.

chart

Atacama Resources International, Inc. (ACRL)

MarketWatch and OTC Markets reported on Atacama Resources International, Inc. (ACRL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Atacama Resources International, Inc. has significant mining claims in the greater Kirkland Lake area of Northern Ontario. Metals and minerals under potential exploration include gold, silver, diamonds, graphite and cobalt. Furthermore, major deposits of copper and iron ore are included in the mining claims. Atacama Resources International is headquartered in Plantation, Florida.

Regarding Minerals, the Company has numerous claims on 4460 acres in the Kirkland Lake and other areas of mineral-rich northern Ontario. The Company’s initial line of business is a combination of mining, acquisition, as well as development of mining interests in the Kirkland Lake region.

Atacama Resources International announced last September that it engaged Canadian Exploration Services Ltd. (CXS) to conduct a geological evaluation of the Company’s Cabo property. The Cabo property comprises Mining Claim 4225513, located in the Township of Lorrain in the heart of all the high-profile cobalt activity surrounding the historic mining town of Cobalt, Ontario.

Atacama Resources has acquired the mineral rights for the Mystery Graphite Property that comprises 1740 acres situated roughly 60 miles south of Timmins, Ontario. The acquisition of the mineral rights includes receiving core samples collected from numerous diamond drill sites earlier conducted on the property   

Additionally, Atacama Resources is involved in a new line of business that it states will make the highways of the U.S. and Canada safer and saves lives in the process. The Company, as part of its expansion portfolio, acquired Good2Drive™, Inc. Good2Drive, Inc. is a wholly-owned subsidiary of Atacama Resources International. 

Good2Drive™ is an entity that has the rights to an application (app), which detects levels of cognitive awareness and reports those levels in accordance with the users' demands and needs. The Company’s technology business includes the innovative Smartphone application Good2Drive and also follow on products that will be released this year.

Atacama Resources International released Good2Drive in 2017. Good2Drive is a mobile application that enables drivers, corporate fleets, and law enforcement to test a driver's cognitive alertness before getting behind the wheel of a motor vehicle. Good2Drive uses a 60-90 second image matching test using a patented algorithm that was created based on the scientific study of cognitive abilities at different West Coast hospitals and universities.  

Good2Drive’s dedication is to providing Smartphone hosted applications founded on its proprietary testing for cognitive awareness. Its set of Smartphone hosted apps will include cognitive tests for care givers, seniors with impairments, remote employees in potentially hazardous environments, and other situations where it is necessary to be cognitively alert. 

Atacama Resources International also has its Good2Drive/Fleet. This is a mobile application. It enables commercial fleet owners and operators to manage manifold drivers as they test their mental alertness before getting behind the wheel of a vehicle.

This past December, Atacama Resources International announced that it released ‘Fit4Duty’. This is a mobile application that permits companies to test cognitive alertness for its employees before getting behind the wheel of a company vehicle and for employees working in potentially hazardous work assignments. Fit4Duty includes a 60-90 second image matching test utilizing a patented algorithm.

Atacama Resources International, Inc. (ACRL), closed Friday's trading session at $0.0034, up 36.00%, on 6,844,690 volume with 86 trades. The average volume for the last 3 months is 5,702,967 and the stock's 52-week low/high is $0.00019/$0.00449.

chart

TransAKT Ltd. (TAKD)

OTC Markets, Stockhouse, Barchart, and The Street reported on TransAKT Ltd. (TAKD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

TransAKT Ltd. is a manufacturer of highly unique agricultural equipment used to grow a broad array of vegetables and fruit employing simulated sunlight from LED lamps in an indoor proprietary hydroponic system. In addition, the Company is an international distributor of LED lighting products centered on serving the fastest developing market of commercial, hospitality, and outdoor lighting. OTCQB-listed, TransAKT is based in Hong Kong.

The Company’s commitment is to helping business owners protect the environment through superior energy efficiency - replacing current non-energy-efficient light sources with energy-efficient light sources. Additionally, TransAKT is focusing on eliminating the use of chemical fertilizers and pesticides utilizing the latest hydroponic agricultural technology and pure nutrients.

The nutrient solutions used in production with its hydroponic systems leave no heavy metal and chemical residues. TransAKT’s product line includes commercial production and home growing systems.

TransAKT’s wholly-owned subsidiary is Vegfab Agriculture Technology Co., Ltd. Vegfab was created in 2010 by a team of ecologically minded semiconductor specialists knowledgeable about LED materials.  

Furthermore, TransAKT is looking for opportunities to develop a BIO-technology business in China. The Company says that the cordyceps business is one project with the greatest potential. It has engaged a team of approximately 10 experts in BIO technology engineering to develop an extended product mix. These products will debut in China in the next few years. 

Vegfab’s product line includes systems for commercial production and a home growing system, which enables families to grow safe and clean fruit and vegetables in their homes. Vegfab products are the subject of numerous patents. These include ones for vertically wall-mounted LED lights, and ventilation systems for grow boxes. 

Vegfab provides complete growing systems consisting of proprietary simulated sunlight LED boards; growing racks in diverse configurations for commercial and residential applications; environment control and plant nutrition control components; portable work tables and ladders; fruit and vegetable seeds and nutrition products; and vegetables. 

Vegfab’s vegetable production factory in Yangmei City, Taiwan is the only mass production facility for vegetables in Taiwan. The facility utilizes innovative technology to produce exceptional yields from a very small space. Production is very efficient through the use of simulated sunlight from LED lamps, up to 85 percent automated. 

TransAKT Ltd. (TAKD), closed Friday's trading session at $0.096, up 317.39%, on 100 volume with 1 trade. The average volume for the last 3 months is 223 and the stock's 52-week low/high is $0.0149/$0.159.

chart

TurnKey Capital, Inc. (TKCI)

MarketWatch, InvestorsHub, and TradingView reported on TurnKey Capital, Inc. (TKCI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, TurnKey Capital, Inc. aligns with and builds value in private, public, and development-stage companies. It works to identify opportunities in high-growth sectors, with an initial concentration on the developing cannabis industry. The Company formerly went by the name Train Travel Holdings, Inc. It changed its corporate name to TurnKey Capital, Inc. in February 2016.  TurnKey Capital is headquartered in Fort Lauderdale, Florida.

A business advisory enterprise, Turnkey Capital provides a wide array of services. These include equity and debt financing for growth, strategic operational and management resources, and financial advice, modeling, and long term corporate and shareholder support.

The Company engages companies that have missing elements within the financials and operations of their company. These missing elements restrict companies’ ability to expand.

Turnkey Capital establishes value for company shareholders through securing debt and equity positions in select companies. As a result, the Company builds a group of undervalued businesses, which it will work to increase in value. Therefore, this enables TurnKey Capital shareholders to benefit from enhanced value alongside client companies.

In January 2017, Turnkey Capital announced that it executed a Letter of Intent (LOI) with Brand Strategy Group International. This is to engage in brand license and management within an extensive range of categories.

TurnKey Capital has identified Brand Strategy Group, Inc. (BSGI) as its first potential licensing partner. Brand Strategy Group owns all intellectual property (IP), licenses, trademarks, and trade names associated with the men's fashion brand, Phillip Acker™. 

Recently, Turnkey Capital announced that it signed a strategic alliance agreement with Seminole Indian Company. This agreement is to provide business formation, development, as well as financial infrastructure services to unique opportunities afforded by tribal sovereignty.

Leading the Seminole Indian Company team is former Seminole Tribal Chairman, Mr. James E. Billie. Mr. Billie is credited with kindling the $33 billion Indian gambling industry.

Important requirements of TurnKey Capital are capital structure and shareholder relations. In essence, the Company approaches venture-capital from a financial viewpoint.

TurnKey Capital, Inc. (TKCI), closed Friday's trading session at $0.0238, up 48.75%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 10,542 and the stock's 52-week low/high is $0.0109/$0.109.

chart

The QualityStocks Company Corner

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE:TCAN) (XETR:TH8) announces the availability of an audio press release titled, “Acquisitions Reveal the Steadily Changing Shape of the Cannabis Sector.” To hear the CannabisNewsAudio version, visit: http://cnw.fm/T0d0X. To read the full editorial, visit: http://cnw.fm/G8nPH.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.

Ecosystem

TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.

The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.

Growing Portfolio

Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.

On Deck

The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.

TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.

Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).

Management

TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.

Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.

Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.

Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

TransCanna Holdings Inc. (CSE: TCAN), closed Friday's trading session at $4.85, up 5.66%, on 66,162 volume with 315 trades. The average volume for the last 3 months is 151,292 and the stock's 52-week low/high is $0.769/$7.789.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) was featured today in the 420 with CNW by CannabisNewsWire. If, as is widely expected, Gov. Pritzker signs a bill that was passed to legalize recreational cannabis in Illinois, the state’s legalization law will be different from all others in several aspects.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $1.1841, up 0.35%, on 207,664 volume with 282 trades. The average volume for the last 3 months is 441,901 and the stock's 52-week low/high is $0.85/$2.039.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a global developer and provider of cellular communications systems, recently achieved a major milestone with the launch of its FirstNet Ready Uniden UV350 4G/LTE In-Vehicle Device for Public Safety (http://nnw.fm/vhW8m). To view the full article, visit: http://nnw.fm/8rIgG.

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Friday's trading session at $0.3661, up 0.58%, on 112,782 volume with 9 trades. The average volume for the last 3 months is 59,501 and the stock's 52-week low/high is $0.254/$0.446.

Recent News

chart

Endonovo Therapeutics Inc. (ENDV)

The QualityStocks Daily Newsletter would like to spotlight Endonovo Therapeutics Inc. (ENDV).

Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic devices, today announces the appointment of Steven Levin, M.D., to its scientific advisory board. Dr. Levin will work with the Endonovo team to facilitate the introduction of SofPulse® to healthcare facilities and further develop the Electroceutical™ devices pipeline.

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.

In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.

Flagship Therapy

SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?

Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.

Certifications

Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.

Management

Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.

Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?

Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.

Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.

Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.

David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.

Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.

Endonovo Therapeutics Inc. (ENDV), closed Friday's trading session at $0.0179, up 5.29%, on 38,475,329 volume with 496 trades. The average volume for the last 3 months is 3,638,664 and the stock's 52-week low/high is $0.0089/$0.0661.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING) and Direct Solar today announced that the company is developing a solar lending solution to serve customers who own and/or manage commercial properties. According to the update, Direct Solar will be one of the first companies to offer this type of lending solution, which is a market opportunity that fills a gap in the commercial space. To view the full press release, visit: http://nnw.fm/6vHy8. Also today, ecommerce site SingleSeed.com received an overwhelming response to the news of LALPINA CBD Water, a brand of American Premium Water Company (OTC: HIPH). The companies are ecstatic for the response and demand for LALPINA CBD seen thus far. LALPINA CBD has consistently been a top seller on the site and multiple reorders have occurred. Unfortunately, the website saw so much traffic yesterday it crashed and caused a delay in ordering. The site has since been restored and more resources have been added. For the inconvenience we are offering a 10% discount on LALPINA CBD Water products through the weekend using the code crash at checkout.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Friday's trading session at $0.017295, up 6.10%, on 20,140,008 volume with 644 trades. The average volume for the last 3 months is 4,419,558 and the stock's 52-week low/high is $0.009/$0.052.

Recent News

chart

MustGrow Biologics Corp.

The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..

MustGrow Biologics, an agricultural biotech company, is developing and commercializing a natural biopesticide and bio-fertilizer that offers an alternative to cannabis and fruit and vegetable growers that are unable to use synthetic pesticides and fertilizers. A recent article discussing the company reads, “MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. Continued use of modern synthetic crop protection products can create a resistance to these conventional products among pests. Advancements in integrated pest management solutions, along with an increase in organic farming, is expected to push the biopesticides market beyond $6 billion by 2023, ResearchandMarkets reports (http://ibn.fm/3v9FA).

MustGrow Biologics Corp. is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.

Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients?(http://nnw.fm/Qkz21).?For the past 50 years,?nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.

MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.

MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.

Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:

  • 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
  • 55 percent tomato crop yield increase
  • 95 percent control of Pythium root rot in lettuce fields
  • 70 percent reduction in Verticillium root severity in cucumbers
  • Market Opportunity

Market Opportunity??

MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?

Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??

MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.

Management Team

President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.

Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.

COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.

Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.

Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.

CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.

Recent News

chart

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)

The QualityStocks Daily Newsletter would like to spotlight Therma Bright, Inc. (OTC: THRBF).

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) was featured today in the 420 with CNW by CannabisNewsWire. If, as is widely expected, Gov. Pritzker signs a bill that was passed to legalize recreational cannabis in Illinois, the state’s legalization law will be different from all others in several aspects. First, Illinois will have defied the odds to legalize adult-use marijuana legislatively. All the other ten states have done so through voter initiatives. Lawmakers in New Jersey and New York at one time seemed poised to pass bills legalizing recreational marijuana but intraparty disagreements have torpedoed those plans.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.

Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.

The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.

Products

The company currently has two products on the market and another in the research and development phase:

InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.

InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.

The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.

Cannabis

Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.

Market Opportunity

A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.

Management

Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.

**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.

Therma Bright, Inc. (OTC: THRBF), closed Friday's trading session at $0.022, even for the day, on 250 volume. The average volume for the last 3 months is 3 and the stock's 52-week low/high is $0.009/$0.0289.

Recent News

chart

Hemptown USA

The QualityStocks Daily Newsletter would like to spotlight Hemptown USA.

Cannabigerol (CBG) ranks among the cannabinoids that will potentially change the future of the cannabis product market. While CBD currently dominates the landscape, scientific advances and genetics could contribute to the rising prominence of CBG in the future. Currently, the CBG content in most plants is very low – it remains less than one percent. However, genetics programs can boost that concentration and increase extraction yield. Currently, the CBG content in most plants is very low – it remains less than one percent. However, genetics programs can boost that concentration and increase extraction yield. One of the companies at the forefront of CBG’s rise to prominence is Hemptown USA. With its 500-acre outdoor production facility in Oregon focused exclusively on CBG, and with access to over one million rare CBG seeds programmed to yield between 15 and 20 percent CBG, Hemptown is positioned to dominate the market.

Hemptown USA, headquartered in Central Point, Oregon, is a proven grower of full-spectrum hemp biomass grown using premium seed genetics that contain less than 0.3% THC and exceptionally high cannabinoid (CBD) content of up to 20%. The company's "soil to oil" methodology combines seasoned professionals working in hand-picked agricultural microclimates located in Oregon's famed Emerald Triangle, Kentucky and Colorado.

Hemptown has exclusive rights to 1 million rare CBG (cannabigerol) seeds genetically programmed to yield from 15% to 20% full-spectrum non-intoxicating cannabinoids. As a result of a long-standing relationship with the one of the world's most respected cannabis breeding companies – Oregon CBD Seeds – Hemptown is positioned to be a leading CBG producer in the U.S. in 2019 and beyond.

In 2018 Hemptown's harvest from its Oregon hemp farm was 150,000 pounds of full-spectrum biomass with CBD content hovering around 17%. 2018 harvest revenue expected to range from $8.1 million to $12.6 million. The company is scaling up operations in 2019 to meet market demands and projects it will reap over 1,000,000 pounds. By 2020, Hemptown projects potential revenues in the $100 million to $200 million range are possible once additional farming operations are at full strength.

Growth Strategy

By 2020, Hemptown anticipates it will have more than 3,000 acres in several states dedicated to hemp farming. Expansion plans include increasing in-house extraction capabilities to boost profit margins by providing additional CBD and CBG isolates and distillation services. Development of business-to-business channels as well as new products and formulations for the direct-to-consumer market, along with several strategic acquisitions, are also key to Hemptown's growth strategy.

Hemptown plans to expand distribution and growing operations globally through strategic partnerships and development of contracts with leading Fortune 500 brands in European markets. The company intends to grow its IP portfolio by developing a proprietary water-soluble cannabinoid delivery system. Not to be confused with water-compatibility, water-soluble cannabinoids combine seamlessly with other liquids, have a superior shelf life, and deliver dramatically increased efficacy to the consumer.

Branded Products

Hemptown's first in-house branded product line combines the inspiring strength found in the unbridled nature that surrounds the company's original hemp farm in the Siskiyou Klamath region of Oregon. Sisku is set to redefine the cannabinoid packaged goods space with an elegant look, clean feel and potent, reliable efficacy.

Custom product lines can also be created for any product manufacturer as Hemptown brings GMP and ISO accredited processing facilities online in 2019. Together with Oregon CBD Seeds and Hemptown's product sciences team, Hemptown will be able to create custom, proprietary full-spectrum CBD and CBG oils and pure isolates.

Management Team

Company Chairman Rod Wolterman founded Hemptown's Oregon operations in 2016. He has extensive experience in the cannabis sector having been active within the space since 1998. Wolterman has also acted as a private equity investor in numerous medical marijuana dispensaries and cultivation operations in southern California.

CEO John Cummings has over 20 years of experience in finance, marketing, sales and project management. He led the compliance and special projects efforts for Kings Garden, one of the largest vertically integrated operators in California. Cummings also spent a year in Europe launching the continent's first GMP and ISO-accredited cultivation and manufacturing facility.

Dr. Gordon Chiu is chief science officer for Hemptown USA. He has more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries. A graduate of Rensselaer Polytechnic Institute with a master's degree from Seton Hall University, Chiu is leading Hemptown's cannabinoid research team and is responsible for filing IP patents, specifically in the areas of water-solubility, bioavailability and peptide sequencing.


Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element (NASDAQ: NETE), a worldwide technology and value-added solutions group, on Thursday announced that Aptito, the company’s cloud-based, restaurant and retail point-of-sale solution, will capitalize on the growing trend of cryptocurrency by processing cryptocurrency payments. To view the full press release, visit: http://nnw.fm/mQ7zh.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Friday's trading session at $4.18, off by 1.88%, on 40,954 volume with 224 trades. The average volume for the last 3 months is 50,467 and the stock's 52-week low/high is $3.75/$10.60.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTCQB: GRYN) recently announced its entry into a multiyear purchase order for the sale of hemp to U.S. Tobacco de Mexico, an industry leader with over 20 different brands of CBD hemp cigarettes (http://nnw.fm/mKA8N). The lucrative five-year contract will require Green Hygienics to deliver $56.4 million worth of hemp flower to the Tijuana, Mexico-based firm for use in its production lines.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed Friday's trading session at $1.5532, off by 3.20%, on 1,993 volume with 12 trades. The average volume for the last 3 months is 19,706 and the stock's 52-week low/high is $0.1001/$1.809.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) patented drug-delivery platform, DehydraTECH, has exhibited continued success in recent animal lab tests by delivering cannabinoids to the bloodstream faster than conventional cannabinoid formulations (http://nnw.fm/fsKW4). To view the full article, visit: http://nnw.fm/6sIqz. Also today, the company announced the results of the 2019 Annual and Special Meeting (the "Meeting").

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Friday's trading session at $0.845, off by 0.58%, on 49,624 volume with 49 trades. The average volume for the last 3 months is 95,965 and the stock's 52-week low/high is $0.75/$2.24.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) recently announced its first commercial sale of cannabis flower in Canada. Selling cannabis flower commercially to a recognized and licensed producer is a major milestone, Sproutly CEO Keith Dolo said in a company news release (http://nnw.fm/HAmf9). Also today, NetworkNewsWire released a report on the company detailing how SRUTF is working toward its goal to establish itself as the leading supplier of water-soluble cannabis solutions and bio-natural oils for beverages and edibles. To view the full article, visit: http://nnw.fm/pe5I3.

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed Friday's trading session at $0.512, off by 6.57%, on 193,767 volume with 159 trades. The average volume for the last 3 months is 808,914 and the stock's 52-week low/high is $0.189/$1.875.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities. To view the full publication, titled “Searching for the Next Super Nova,” visit: http://nnw.fm/P7LFo.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed Friday's trading session at $0.4821, off by 1.33%, on 20,987 volume with 7 trades. The average volume for the last 3 months is 24,091 and the stock's 52-week low/high is $0.009/$1.129.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD), a major supplier to the growing hydroponic cultivation sector, recently announced that it intends to utilize its access to advanced Chinese extraction technologies to enter the hemp CBD extraction equipment and technologies market (http://nnw.fm/1qlSN). To view the full article, visit: http://nnw.fm/UJp4Y.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Friday's trading session at $0.0305, off by 7.58%, on 951,485 volume with 52 trades. The average volume for the last 3 months is 1,665,410 and the stock's 52-week low/high is $0.0225/$0.1975

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.